Skip to content
WeighLab
Menu
Ranked #49 · Grade C

Maves review

Maves (operated by parent company Homera Health) is a men's-health/performance-framed telehealth platform offering compounded semaglutide and tirzepatide plus sermorelin.

Visit Maves Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$89/mo (starting dose, compounded)
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$1,068

Pricing verified August 2026

The Index scorecard

Maves scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month82/100
Price Transparency78/100
Nationwide Access86/100
Formulation Options66/100
Clinical Oversight75/100
Contract Flexibility55/100

Where the value is

  • LegitScript badge displayed on the site
  • Publishes the FDA compounded-medication disclaimer
  • Low advertised semaglutide entry price ($89-99/mo range)
  • Both brand (Maves) and parent (Homera Health) are disclosed
  • All 50 states served, stated explicitly

The tradeoffs

  • The homepage shows two different numbers for the same starting semaglutide tier ($89/month vs $99 first month) with no reconciliation — the real ongoing price cannot be confirmed from the public site
  • Tirzepatide is listed as an offering but no price is published anywhere reachable on the site, confirmed by direct search
  • Compounding pharmacy is not named, only 'licensed U.S. pharmacies'
  • No medical director or clinical leadership named
  • Refund and cancellation policy not published publicly

The bottom line

Best for: Shoppers drawn to aggressive low intro pricing on semaglutide who will confirm the exact charge before checkout. Maves (operated by parent company Homera Health) is a men's-health/performance-framed telehealth platform offering compounded semaglutide and tirzepatide plus sermorelin.

Ranked #49 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Maves.

The 24 programs nearest this one

Pricing, states and verification reflect Maves's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Maves's site. Not medical advice; see our disclosure.

← Back to the value leaderboard